D |
2021-07-21 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
D-Return |
--D |
120253.0000 |
0.0000 |
1 |
0000899866 |
Common Stock, par value $.0001 per share |
A |
2021-07-14 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
29501.0000 |
120253.0000 |
2 |
0000899866 |
Common Stock, par value $.0001 per share |
A |
2021-07-14 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
26812.0000 |
90752.0000 |
1 |
0000899866 |
Common Stock, par value $.0001 per share |
A |
2021-02-28 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
24473.0000 |
63940.0000 |
1 |
0000899866 |
Common Stock, par value $.0001 per share |
D |
2020-12-16 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
F-InKind |
--D |
2510.0000 |
39467.0000 |
3 |
0000899866 |
Common Stock, par value $.0001 per share |
D |
2020-12-16 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
F-InKind |
--D |
6853.0000 |
41977.0000 |
2 |
0000899866 |
Common Stock, par value $.0001 per share |
A |
2020-12-16 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
15371.0000 |
48830.0000 |
1 |
0000899866 |
Common Stock, par value $.0001 per share |
D |
2020-11-30 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
F-InKind |
--D |
1298.0000 |
33459.0000 |
1 |
0000899866 |
Common Stock, par value $.0001 per share |
D |
2020-03-02 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
F-InKind |
--D |
883.0000 |
34757.0000 |
2 |
0000899866 |
Common Stock, par value $.0001 per share |
A |
2020-02-28 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
10880.0000 |
35640.0000 |
1 |
0000899866 |
Common Stock, par value $.0001 per share |
D |
2019-12-02 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
F-InKind |
--D |
5441.0000 |
24760.0000 |
1 |
0000899866 |
Common Stock, par value $.0001 per share |
D |
2019-06-21 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
578.0000 |
30201.0000 |
1 |
0000899866 |
Common Stock, par value $.0001 per share |
A |
2019-05-21 |
|
ORASURE TECHNOLOGIES INC |
4 |
A-Award |
--D |
12382.0000 |
16865.0000 |
1 |
0001116463 |
Common Stock |
D |
2019-05-06 |
|
ORASURE TECHNOLOGIES INC |
4 |
F-InKind |
--D |
1661.0000 |
4483.0000 |
1 |
0001116463 |
Common Stock |
A |
2019-02-28 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
8250.0000 |
30779.0000 |
1 |
0000899866 |
Common Stock, par value $.0001 per share |
D |
2019-02-28 |
|
ALEXION PHARMACEUTICALS, INC. |
4 |
F-InKind |
--D |
267.0000 |
22529.0000 |
1 |
0000899866 |
Common Stock, par value $.0001 per share |
A |
2018-05-08 |
|
ORASURE TECHNOLOGIES INC |
4 |
A-Award |
--D |
6144.0000 |
6144.0000 |
1 |
0001116463 |
Common stock |
A |
2018-01-31 |
|
ORASURE TECHNOLOGIES INC |
4 |
A-Award |
--D |
40000.0000 |
40000.0000 |
1 |
0001116463 |
Non-qualified stock options |
- |
- |
|
ORASURE TECHNOLOGIES INC |
3 |
- |
--- |
|
|
1 |
- |
- |
- |
- |
|
ALEXION PHARMACEUTICALS, INC. |
3 |
- |
--D |
|
209.0000 |
4 |
0000899866 |
Common Stock, par value $.0001 per share |
- |
- |
|
ALEXION PHARMACEUTICALS, INC. |
3 |
- |
--D |
|
3378.0000 |
3 |
0000899866 |
Common Stock, par value $.0001 per share |
- |
- |
|
ALEXION PHARMACEUTICALS, INC. |
3 |
- |
--D |
|
8731.0000 |
2 |
0000899866 |
Common Stock, par value $.0001 per share |
- |
- |
|
ALEXION PHARMACEUTICALS, INC. |
3 |
- |
--D |
|
10478.0000 |
1 |
0000899866 |
Common Stock, par value $.0001 per share |